Axon shares dropped 20% after reporting a Q3 profit miss tied to tariff costs, though revenue exceeded forecasts at $710.6 ...

Biohaven dropped 44% in premarket trading after the FDA declined to approve Vyglxia, citing issues with trial design even as ...

McDonald's Q3 2025 results showed a 3.6% rise in global sales, while EPS of $3.18 came in just below forecasts.

Emerson’s Q4 2025 results showed steady growth, with EPS meeting expectations and revenue slightly below estimates.

Humana’s third-quarter results beat expectations with adjusted EPS of $3.24 and revenue of $32.65 billion, as the company ...

Michael Burry’s sizable put options on PLTR suggest cautious skepticism, even as the stock’s memetic narrative fuels ...

TradeZero has officially launched TradeZero Europe B.V. in the Netherlands, bringing its advanced trading platform and ...

Denny’s stock surged 46% in premarket trading after agreeing to a $620 million take-private deal with TriArtisan Capital ...

Uber’s third-quarter performance exceeded forecasts, highlighting solid growth and continued confidence in its outlook for ...

Palantir stock fell 8% in premarket trading despite beating Q3 estimates and raising guidance, as valuation concerns and ...

Pfizer reported Q3 2025 revenue of $16.7 billion and adjusted EPS of $0.87, beating expectations and prompting a full-year ...

Eaton Corporation plc (NYSE: ETN) reported record results for the third quarter of 2025, driven by strong order growth and ...